FDA questions role of payments in Zimmer study - The Associated Press

FDA questions role of payments in Zimmer study
The Associated Press
Shares of Zimmer Holdings Inc. fell 4 cents Monday in after-hours trading to $52.73, having closed earlier up 20 cents at $52.77.